Aimei Health Technology Co., Ltd filed an amended current report on November 2, 2026, covering an October 5, 2026 event, to correct a reference in its previously filed report and to disclose the issuance of a $34,330.96 unsecured promissory note funding a one-month extension of its business combination deadline.

Key Highlights

  • Amendment purpose: The filing amends the original October 5, 2026 current report solely to remove a reference to "United Hydrogen" in the description of the Promissory Note; no other information was changed.
  • Extension Payment: An aggregate of $34,330.96 was deposited into the Company's trust account for public shareholders, representing the lesser of $80,000 for all outstanding public shares or $0.033 per outstanding public share per monthly extension.
  • Deadline extended: The Extension moves the termination date from October 6, 2026 to November 6, 2026, and is described as the twenty-third extension permitted under the Amended and Restated Articles of Association.
  • Promissory Note terms: The $34,330.96 unsecured note was issued to Aimei Investment Ltd, bears no interest, and is due upon consummation of a business combination.
  • Conversion right: The payee may convert the note, in whole or in part, into private units at $10.00 per unit, each consisting of one ordinary share and one right to receive one-fifth of one ordinary share, immediately prior to closing of a business combination.
  • Issuer status: The company is designated an emerging growth company under the applicable Securities Act and Exchange Act definitions.

Aimei Health Issues Note to Fund Twenty-Third SPAC Extension

According to the filing, Aimei Health Technology Co., Ltd (NASDAQ:AFJK), a Cayman Islands-incorporated special purpose acquisition company, deposited $34,330.96 into its trust account on or around October 5, 2026, enabling a one-month extension of the period during which it may complete an initial business combination. The filing identifies this as the twenty-third such extension under the company's Amended and Restated Articles of Association. The trust deposit was calculated as the lesser of $80,000 for all outstanding public shares or $0.033 for each outstanding public share for each monthly extension period.

To fund the Extension Payment, the company disclosed that it issued an unsecured promissory note in the principal amount of $34,330.96 to Aimei Investment Ltd, a Cayman Islands exempted company identified as the payee. The note carries no interest, and its principal becomes due and payable on the date the company consummates a business combination, according to the filing. The payee holds the right, but not the obligation, to convert the note in whole or in part into private units of the company at $10.00 per unit. Each unit consists of one ordinary share and one right to receive one-fifth of one ordinary share, with any conversion to occur immediately prior to the closing of a business combination, provided the payee delivers written notice at least two business days before closing.

The amendment was filed to correct a specific error in the original October 5, 2026 report. As stated in the explanatory note, the filing was made "solely to remove the reference in Item 2.03 of the Original 8-K to United Hydrogen in the description of the Promissory Note." The company stated that, except for this correction, the amendment does not otherwise amend, modify, or update the information in the original report. The Promissory Note itself is incorporated by reference as Exhibit 10.1 to the filing.

What Was Disclosed

Aimei Health Technology Co., Ltd disclosed a $34,330.96 trust deposit and a corresponding unsecured promissory note issued to Aimei Investment Ltd, extending the company's business combination deadline from October 6, 2026 to November 6, 2026. The amendment also corrected a prior reference to United Hydrogen.